Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunogenicity and Safety of GSK Biologicals' FluLaval® TF

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: August 1, 2008
Last updated: June 14, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)